Venmax Drugs & Pharmaceuticals Ltd

Venmax Drugs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Venmax Drugs & Pharmaceuticals Ltd

₹ 24.5 -2.00%
30 Jun - close price
venmaxdrugs.com BSE: 531015
About

Incorporated in 1998, Venmax Drugs & Pharmaceuticals Ltd is engaged in the business of IT & ITES services[1]

Key Points

Business Overview:[1]
a) VDPL is focused on establishing chain of Medical Stores with a brand name Ananya Pharma under the Venmax Drugs & Pharma Ltd, with the backing support of Formulations plant (Suzichem Labs). Currently, it has established 3 Shops & planning to expand them to 50 numbers around Hyderabad.
b) The company is developing oncology products in R&D. It is planning to establish a manufacturing UNIT with cGMP facility at Pharma Cluster at Hyderabad, to meet the export demand.

Website BSE
  • Market Cap ₹ 12.9 Cr.
  • Current Price ₹ 24.5
  • High / Low ₹ 30.9 / 0.00
  • Stock P/E
  • Book Value ₹ 8.42
  • Dividend Yield 0.00 %
  • ROCE -0.96 %
  • ROE -0.53 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Stock is trading at 2.92 times its book value
  • Company has low interest coverage ratio.
  • Promoter holding is low: 23.1%
  • Company has high debtors of 428 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.10 0.17 0.20 0.33
0.03 0.02 0.06 0.03 0.08 0.03 0.03 0.01 0.04 0.12 0.47 0.69 0.57
Operating Profit -0.03 -0.02 -0.06 -0.03 -0.08 -0.03 -0.03 -0.01 -0.04 -0.02 -0.30 -0.49 -0.24
OPM % -20.00% -176.47% -245.00% -72.73%
1.98 0.05 0.05 0.05 0.27 0.05 0.00 0.05 0.10 0.03 0.00 0.00 1.02
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit before tax 1.95 0.03 -0.01 0.02 0.19 0.02 -0.03 0.04 0.06 0.01 -0.30 -0.49 0.78
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 25.00% 16.67% 0.00% 0.00% 0.00% 0.00%
1.95 0.03 -0.01 0.02 0.19 0.02 -0.03 0.03 0.05 0.01 -0.30 -0.50 0.78
EPS in Rs 3.72 0.06 -0.02 0.04 0.36 0.04 -0.06 0.06 0.10 0.02 -0.57 -0.95 1.49
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.59 2.43 1.93 0.26 0.00 0.15 0.47 0.17 0.00 0.00 0.00 0.81
1.02 2.54 2.07 0.88 0.23 0.38 0.72 0.50 0.12 0.19 0.11 1.87
Operating Profit -0.43 -0.11 -0.14 -0.62 -0.23 -0.23 -0.25 -0.33 -0.12 -0.19 -0.11 -1.06
OPM % -72.88% -4.53% -7.25% -238.46% -153.33% -53.19% -194.12% -130.86%
-1.32 0.00 0.00 -0.72 0.00 0.00 0.00 0.18 1.98 0.42 0.20 1.05
Interest 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.01 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Profit before tax -1.77 -0.11 -0.14 -1.34 -0.24 -0.24 -0.26 -0.16 1.85 0.22 0.08 -0.02
Tax % 29.38% -36.36% 0.00% 0.00% 0.00% 0.00% 3.85% 0.00% 0.00% 0.00% 25.00% 0.00%
-2.30 -0.08 -0.14 -1.34 -0.24 -0.24 -0.27 -0.16 1.85 0.23 0.06 -0.01
EPS in Rs -4.39 -0.15 -0.27 -2.56 -0.46 -0.46 -0.52 -0.31 3.53 0.44 0.11 -0.02
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: -10%
5 Years: 12%
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: 6%
5 Years: 14%
3 Years: %
TTM: -117%
Stock Price CAGR
10 Years: 18%
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: -1%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 5.24 5.24 5.24 5.24 5.24 5.24 5.24 5.24 5.24 5.24 5.24 5.24
Reserves -4.82 -4.90 -5.04 -7.11 -7.35 -7.59 -7.86 -8.03 -6.18 -5.95 -5.89 -0.83
1.40 1.50 1.72 1.85 2.04 2.24 2.52 2.33 0.35 0.35 0.35 0.05
0.92 1.85 0.68 0.16 0.14 0.44 0.56 0.76 0.80 0.57 0.38 0.71
Total Liabilities 2.74 3.69 2.60 0.14 0.07 0.33 0.46 0.30 0.21 0.21 0.08 5.17
0.00 0.00 0.00 0.00 0.00 0.11 0.10 0.09 0.08 0.07 0.07 0.04
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
2.73 3.68 2.59 0.14 0.07 0.22 0.36 0.21 0.13 0.14 0.01 5.13
Total Assets 2.74 3.69 2.60 0.14 0.07 0.33 0.46 0.30 0.21 0.21 0.08 5.17

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.85 -0.10 -0.19 -1.06 -0.26 -0.05 -0.28 0.26 1.91 0.00 0.00 -2.29
1.43 0.00 0.00 0.01 0.00 -0.11 0.00 0.00 0.00 0.00 0.00 0.00
-2.28 0.10 0.22 1.02 0.26 0.16 0.28 -0.19 -1.98 0.00 0.00 4.77
Net Cash Flow 0.00 0.00 0.03 -0.03 0.00 0.00 0.00 0.07 -0.07 0.00 0.00 2.48

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 129.92 21.03 128.60 0.00 0.00 31.06 85.88 428.09
Inventory Days 468.30 225.44 0.00 0.00 446.11 250.94 0.00 27.72
Days Payable 75.75 251.51 1,257.22 456.25 291.08
Cash Conversion Cycle 522.46 -5.04 128.60 0.00 -811.11 -174.25 85.88 164.73
Working Capital Days 420.68 -3.00 5.67 -126.35 -535.33 -155.32 -1,331.18 874.20
ROCE % -10.08% -6.01% -7.45% -52.63% -0.96%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
23.13% 23.13% 23.13% 23.13% 23.13% 23.13% 23.13% 23.13% 23.13% 23.13% 23.13% 23.13%
0.15% 0.15% 0.15% 0.15% 0.15% 0.15% 0.15% 0.15% 0.15% 0.15% 0.15% 0.15%
76.72% 76.72% 76.72% 76.72% 76.71% 76.71% 76.71% 76.71% 76.71% 76.72% 76.72% 76.71%
No. of Shareholders 6,2556,2536,2526,2516,2506,2506,2526,2516,2526,2916,6576,756

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports